CNS inhibitory effects of barakol, a constituent of Cassia siamia Lamk

Journal of Ethnopharmacology

Volumn 83, Issue 1-2, 2002, Pages 87-94

  Sukma, Monrudee ^a   Chaichantipyuth, Chaiyo ^b   Murakami, Yukihisa ^a   Tohda, Michihisa ^a   Matsumoto, Kinzo ^a   Watanabe, Hiroshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Barakol; Cassia siamia; CNS depressant activity; Dopamine release

Indexed keywords

4 AMINOBUTYRIC ACID; BARAKOL; BICUCULLINE; CASSIA SIAMIA LAMK EXTRACT; CONVULSANT AGENT; DOPAMINE; GLYCINE; METHAMPHETAMINE; PENTETRAZOLE; PICROTOXIN; PLANT EXTRACT; STRYCHNINE; THIOPENTAL; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CASSIA SIAMIA LAMK; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG INHIBITION; EXPERIMENTAL TEST; LOCOMOTION; MALE; MAZE TEST; MEDICINAL PLANT; MICRODIALYSIS; NEUROCHEMISTRY; NONHUMAN; PHARMACOLOGY; RAT; RODENT; SEDATION; SLEEP; SLEEP TIME;

ANIMALS; ANTICONVULSANTS; BENZOPYRANS; BICUCULLINE; CASSIA; DIAZEPAM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MAZE LEARNING; METHAMPHETAMINE; PENTYLENETETRAZOLE; PHENALENES; PHYTOTHERAPY; PICROTOXIN; PLANT EXTRACTS; RATS; RATS, WISTAR; SEIZURES; SLEEP; STRYCHNINE; THIOPENTAL;

EID: 0036876696     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-8741(02)00206-4     Document Type: Article

References (31)

1. Arttasit, R., 1987. Medicinal plants in primary health care, Ministry of Public Health, Bangkok.
2. Arunlakshana O. Studies of indigenous drugs: 1. Pharmacological actions of the leaves of Cassia siamea. Siriraj Hospital Gaz. 1:1949;434-443.
3. Asakura W., Matsumoto K., Ohta H., Watanabe H. Effects of alpha 2-adrenergic drugs on REM sleep deprivation-induced increase in swimming activity. Pharmacological Biochemical and Behavior. 46:1993;111-115.
4. Bhengsri, S., 1996. Detection and localization of barakol binding sites in rat brains. M.S. Thesis, Faculty of Pharmacy, Chulalongkorn University, Bangkok.
5. 3 receptors. British Journal of Pharmacology (Supplement). 110:1993;93.
6. Bulyalert D. Effects of barakol on the central nervous system: quantitative analysis of EGG in the rat. Chiang Mai Vechasarn. 32:(4):1993;191-196.
7. Bunyarattanakonkit L. Samunprai Nachai no 1. 1992;Tantong Printing Service, Bangkok.
8. Butcher S.P., Fairbrother I.S., Kelly J.S., Arbuthnott G.W. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study. Journal of Neurochemistry. 50:1988;346-355.
9. Bycroft B.W. The structure and synthesis of barakol: a novel dioxaphenalene derivative from Cassia siamea. Journal of Chemical Society. 12:1970;1686-1689.
10. Chaichantipyuth, C., 1979. A photochemical study of the leaves of Cassia siamea Lamk. and Cassia spectabilis DC. M.S. thesis, Faculty of Pharmacy, Chulalongkorn University, Bangkok.
11. Cooper J.R., Bloom F.E., Roth R.H. The Biochemical Basis of Neuropharmacology. seventh ed. 1996;126-162 Oxford University Press, New York.
12. 3 dopamine receptors in human striatum. Progress in Neuropsychopharmacology Biology and Psychiatry. 19:1995;1147-1154.
13. 3 receptor agonist cis-8-OH-PBZI. European Journal of Pharmacology. 342:(2-3):1998;153-161.
14. Fiorino D.F., Treit D., Menard J., Lermer L., Phillips A.G. Is barakol anxiolytic. Behavioral Pharmacology. 9:1998;375-378.
15. 2 dopaminergic agonist. Journal of Pharmacological Experimental and Therapeutics. 250:1989;227-235.
16. Irwin S. Comprehensive observational assessment: Ia. A systematic quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacology. 13:1968;222.
17. Jantarayota, P., 1987. Actions of barakol on the central nervous system. M.S. thesis, Faculty of Pharmacy, Chulalongkorn University, Bangkok.
18. 3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats. European Neuropsychopharmacology. 8:(2):1998;113-120.
19. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology. 92:1987;180-185.
20. Manosroi, J., 1994. Pesatchakumlanna: Tumrabyasamunprailanna. Ongkantahanpansuk, Bangkok.
21. 3 receptors. European Journal of Pharmacology. 249:1993;R5-R6.
22. Nisoli E., Tonello C., Imhof R., Scherschlicht R., da Prada M., Carruba M.O. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist. The Journal of Pharmacology and Experimental Therapeutics. 266:(1):1993;97-105.
23. Pellow S. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Method. 14:1985;149-167.
24. 2 receptors. Neuroreport. 6:1995;329-332.
25. 3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release. Journal of Neurotransmission (General Section). 95:1994;71-74.
26. Thongsaard W. Physiological and pharmacological properties of Cassia siamea and its active constituent, barakol. Thai Journal of Physiological Science. 11:(1):1998;1-26.
27. Thongsaard W., Deachapunya C., Pongsakorn S., Boyd E.A., Bannett G.W., Marsden C.A. Barakol-a potential anxiolytic extracted from Cassia siamea. Pharmacology Biochemistry and Behavior. 53:1996;753-758.
28. Thongsaard W., Pongsakorn S., Sudsuang R., Bannett G.W., Kendall D.A., Marsden C.A. Barakol, a natural anxiolytic, inhibits striatal dopamine release but not uptake in vitro. European Journal of Pharmacology. 319:1997;157-164.
29. Thongsaard W., Chainakul S., Bennett G.W., Marsden C.A. Determination of barakol extracted from Cassia siamea by HPLC with electrochemical detection. Journal of Pharmaceutical and Biomedical Analysis. 25:(5-6):2001;853-859.
30. Zetterstrom T., Ungerstedt U. Effects of apomorphine on the in vivo release of dopamine and its metabolites, studied by brain dialysis. European Journal of Pharmacology. 97:1984;29-36.
31. Zetterstrom T., Sharp T., Ungerstedt U. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo. Naunyn-Schmiedebergs Archives of Pharmacology. 334:1986;117-124.